These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 30556449)

  • 21. Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes.
    Miguel-Escuder L; Olate-Pérez Á; Sala-Puigdoners A; Moll-Udina A; Figueras-Roca M; Navarro-Angulo MJ; Adán A; Pelegrín L
    Eur J Ophthalmol; 2023 Jan; 33(1):NP23-NP27. PubMed ID: 34836464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluocinolone acetonide for the treatment of diabetic macular edema.
    Veritti D; Sarao V; Diplotti L; Samassa F; Lanzetta P
    Expert Opin Pharmacother; 2017 Oct; 18(14):1507-1516. PubMed ID: 28764565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of a fluocinolone acetonide intravitreal implant for patients with DME based on the FAME study.
    Cutino A; Green K; Kendall R; Moore PT; Zachary C
    Am J Manag Care; 2015 Jan; 21(4 Suppl):S63-72. PubMed ID: 25734663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA.
    Chakravarthy U; Yang Y; Lotery A; Ghanchi F; Bailey C; Holz FG; Downey L; Weber M; Eter N; Dugel PU
    Retina; 2018 Feb; 38(2):343-351. PubMed ID: 28257378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.
    Meireles A; Goldsmith C; El-Ghrably I; Erginay A; Habib M; Pessoa B; Coelho J; Patel T; Tadayoni R; Massin P; Atorf J; Augustin AJ
    Eye (Lond); 2017 May; 31(5):684-690. PubMed ID: 28085139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting.
    Elaraoud I; Andreatta W; Kidess A; Bhatnagar A; Tsaloumas M; Quhill F; Yang Y
    BMC Ophthalmol; 2016 Jan; 16():3. PubMed ID: 26728265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study.
    Mansour SE; Kiernan DF; Roth DB; Eichenbaum D; Holekamp NM; Kaba S; Werts E
    Br J Ophthalmol; 2021 Mar; 105(3):414-419. PubMed ID: 32461262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-economic evaluation of fluocinolone acetonide 190 µg implant in people with diabetic macular edema.
    Holden SE; Currie CJ; Owens DR
    Curr Med Res Opin; 2017 Oct; 33(sup2):45-52. PubMed ID: 28881146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.
    Ciulla TA; Harris A; McIntyre N; Jonescu-Cuypers C
    Expert Opin Pharmacother; 2014 May; 15(7):953-9. PubMed ID: 24661081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom.
    Bailey C; Chakravarthy U; Lotery A; Menon G; Talks J;
    Eye (Lond); 2017 Dec; 31(12):1707-1715. PubMed ID: 28737758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience.
    Fallico M; Maugeri A; Lotery A; Longo A; Bonfiglio V; Russo A; Avitabile T; Furino C; Cennamo G; Barchitta M; Agodi A; Marolo P; Ventre L; Caselgrandi P; Reibaldi M
    Sci Rep; 2021 Feb; 11(1):4800. PubMed ID: 33637841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND).
    Figueira J; Henriques J; Amaro M; Rosas V; Alves D; Cunha-Vaz J
    Ophthalmic Res; 2017; 57(3):166-172. PubMed ID: 28178701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of intravitreal fluocinolone acetonide (Iluvien
    Saedon H; Anand A; Yang YC
    Clin Ophthalmol; 2017; 11():583-590. PubMed ID: 28392675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants.
    Yang Y; Bailey C; Holz FG; Eter N; Weber M; Baker C; Kiss S; Menchini U; Ruiz Moreno JM; Dugel P; Lotery A;
    Eye (Lond); 2015 Sep; 29(9):1173-80. PubMed ID: 26113503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor and diabetic macular edema.
    Lally DR; Shah CP; Heier JS
    Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients.
    Studsgaard A; Clemmensen KØ; Nielsen MS
    Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1633-1639. PubMed ID: 34851465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.
    Mohamed QA; Fletcher EC; Buckle M
    BMJ Clin Evid; 2016 Mar; 2016():. PubMed ID: 27031563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
    Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
    Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic macular oedema: pathophysiology, management challenges and treatment resistance.
    Bahrami B; Zhu M; Hong T; Chang A
    Diabetologia; 2016 Aug; 59(8):1594-608. PubMed ID: 27179659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluocinolone acetonide for the treatment of diabetic macular edema.
    Haritoglou C; Mayer W; Wolf A
    Expert Rev Clin Pharmacol; 2016; 9(3):367-74. PubMed ID: 26681198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.